Pet food supplement
This disclosure relates to methods of treating anal gland disease in subjects. In particular, the disclosure provides supplement compositions useful for treatment of anal gland disease. Such compositions comprise a probiotic, a fiber source, and an anti-inflammatory agent.
1. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising (1) a probiotic, a prebiotic, or both, (2) a fiber source, and (3) an anti-inflammatory agent selected from the group consisting of fish oil, bioflavonoid, bromelain, Vitamin C, Vitamin E, L-glutathione, selenium, resveratrol, papain, flax seed oil, curcumin, ginger, alpha lipoic acid, zinc, quercetin, and a combination thereof.
2. The method according to claim 1 , wherein the subject is a dog or a cat.
3. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising (1) two or more fiber sources, (2) an anti-inflammatory agent selected from the group consisting of fish oil, bioflavonoid, bromelain, Vitamin C, Vitamin E, L-glutathione, selenium, resveratrol, papain, flax seed oil, curcumin, ginger, alpha lipoic acid, zinc, quercetin, and a combination thereof, and (3) optionally one additional agent selected from the group selected from a probiotic, a prebiotic, an anti-histamine, an antibiotic, and an anti-diarrhea agent.
4. The method according to claim 3 , wherein the subject is a dog or a cat.
5. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising two or more fiber sources and an anti-inflammatory agent selected from bromelain, quercetin, or a combination thereof.
6. The method according to claim 5 , wherein one fiber source is pumpkin or pumpkin seed.
7. The method according to claim 1 , wherein the probiotic is a strain selected from the group consisting of Bifidobacterium, Lactobacillus, Lactococcus, Saccharomyces, Streptococcus , and a combination thereof.
8. The method according to claim 7 , wherein the probiotic is Lactobacillus acidophilus.
9. The method according to claim 1 , wherein the fiber source is selected from the group consisting of barley, flax seed, digestion resistant maltodextrin, beet pulp, guar gum, inulin, cellulose, larch arabinogalactan, methylcellulose, oat bran, oligofructose, pectin, pumpkin powder, pumpkin seed, psyllium, rice bran, wheat bran, wheat dextrin, and a combination thereof.
10. The method according to claim 1 , wherein the anti-inflammatory agent is bromelain, quercetin, or a combination thereof.
11. The method according to claim 1 , wherein the composition comprises: L. Acidophilus , pumpkin seed, quercetin, and bromelain.
12. The method according to claim 3 , wherein the probiotic is a strain selected from the group consisting of Bifidobacterium, Lactobacillus, Lactococcus, Saccharomyces, Streptococcus , and a combination thereof.
13. The method according to claim 12 , wherein the probiotic is Lactobacillus acidophilus.
14. The method according to claim 3 , wherein the fiber source is selected from the group consisting of barley, flax seed, digestion resistant maltodextrin, beet pulp, guar gum, inulin, cellulose, larch arabinogalactan, methylcellulose, oat bran, oligofructose, pectin, pumpkin powder, pumpkin seed, psyllium, rice bran, wheat bran, wheat dextrin, and a combination thereof.
15. The method according to claim 3 , wherein the anti-inflammatory agent is bromelain, quercetin, or a combination thereof.
16. The method according to claim 3 , wherein the composition comprises: L. Acidophilus , pumpkin seed, quercetin, and bromelain.
17. The method according to claim 1 , wherein the anti-inflammatory agent is quercetin, where quercetin is present in the amount of about 3 weight % to about 15 weight %.
18. The method according to claim 17 , wherein the composition further comprising a digestive enzyme.
19. The method according to claim 18 , wherein the digestive enzyme is bromelain.
20. The method according to claim 18 , wherein the composition further comprising apple pectin.
21. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising (1) a probiotic, a prebiotic, or both, (2) a fiber source, and (3) an anti-inflammatory agent selected from the group consisting of fish oil, bioflavonoid, bromelain, Vitamin C, Vitamin E, L-glutathione, selenium, resveratrol, papain, flax seed oil, curcumin, ginger, alpha lipoic acid, zinc, quercetin, and a combination thereof, wherein the administration is oral.
22. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising (1) two or more fiber sources, (2) an anti-inflammatory agent selected from the group consisting of fish oil, bioflavonoid, bromelain, Vitamin C, Vitamin E, L-glutathione, selenium, resveratrol, papain, flax seed oil, curcumin, ginger, alpha lipoic acid, zinc, quercetin, and a combination thereof, and (3) optionally one additional agent selected from the group selected from a probiotic, a prebiotic, an anti-histamine, an antibiotic, and an anti-diarrhea agent, wherein the administration is oral.
23. The method according to claim 21 , wherein the anti-inflammatory agent is bromelain, Vitamin C, Vitamin E, quercetin, or a combination thereof.
24. The method according to claim 22 , wherein the anti-inflammatory agent is bromelain, Vitamin C, Vitamin E, quercetin, or a combination thereof.